Raffan E, McCallum A, Scase T J, Watson P J
Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
J Vet Intern Med. 2009 Jan-Feb;23(1):63-6. doi: 10.1111/j.1939-1676.2008.0230.x.
Chronic hepatitis (CH) in dogs is common but little is known about factors associated with survival. Ascites is a well-recognized negative prognostic indicator in humans.
Ascites is a negative prognostic indicator in CH in dogs.
Thirty-four dogs with histologically confirmed CH presented to 1 institution between 1996 and 2005.
Retrospective observational study. CH was diagnosed by histopathology of liver tissue according to the WSAVA criteria. Ascites was diagnosed by abdominal ultrasound. The association of ascites with survival from diagnosis or onset of owner-reported clinical signs until death from any cause or from liver disease was analyzed. Ascitic and nonascitic groups were further analyzed for differences in treatment and sex.
Fourteen of 34 dogs had ascites. Survival from diagnosis to death from liver disease was 0.4 months (95% confidence interval [CI], 0.2-0.6) for ascitic dogs and 24.3 months (CI 11.4-37.1) for nonascitic dogs (P < .001), and from onset of signs to death from liver disease was 2.0 months (CI 0.0-5.6) for ascitic dogs and 33.0 months (CI 8.6-57.4) for nonascitic dogs (P= .0020). Diet and spironolactone use differed between groups.
Ascites is a significant negative prognostic indicator in dogs with CH. Veterinarians and owners can use this information to aid clinical decision making in affected dogs.
犬慢性肝炎(CH)很常见,但与生存相关的因素却鲜为人知。腹水在人类中是公认的不良预后指标。
腹水是犬CH的不良预后指标。
1996年至2005年间,34只经组织学确诊为CH的犬被送至一家机构。
回顾性观察研究。根据世界小动物兽医师协会(WSAVA)标准,通过肝组织病理学诊断CH。通过腹部超声诊断腹水。分析腹水与从诊断或主人报告的临床症状出现到因任何原因或肝病死亡的生存之间的关联。进一步分析腹水组和非腹水组在治疗和性别方面的差异。
34只犬中有14只出现腹水。腹水犬从诊断到死于肝病的生存期为0.4个月(95%置信区间[CI],0.2 - 0.6),非腹水犬为24.3个月(CI 11.4 - 37.1)(P <.001);腹水犬从症状出现到死于肝病的生存期为2.0个月(CI 0.0 - 5.6),非腹水犬为33.0个月(CI 8.6 - 57.4)(P =.0020)。两组在饮食和螺内酯使用方面存在差异。
腹水是犬CH的重要不良预后指标。兽医和主人可利用此信息辅助对患病犬的临床决策。